Small cap, well covered — what the screen found 2026-10-23
Manufacturing dominates this latest scan, accounting for 26 of the 40 companies that matched the criteria on October 22, 2026. The results are heavily concentrated in one sector rather than spread across the broader market.
Key figures
Data as of Oct 23, 2026- VNRX (VolitionRx Limited) market cap
- $4.90M
- APRE (Aprea Therapeutics, Inc. Common stock) market cap
- $6.61M
- MERC (Mercer International Inc) market cap
- $9.46M
- KPTI (Karyopharm Therapeutics Inc.) market cap
- $11.99M
- TVRD (Tvardi Therapeutics, Inc. Common Stock) market cap
- $13.33M
- ACH (Accendra Health, Inc.) market cap
- $15.73M
Manufacturing dominates this latest scan, accounting for 26 of the 40 companies¹˒² that matched the criteria on October 22, 2026. The results are heavily concentrated in one sector rather than spread across the broader market.
Among the matching names are several small-cap companies in Manufacturing, including VolitionRx Limited ($4.90M³), Aprea Therapeutics, Inc. ($6.61M⁴), Mercer International Inc ($9.46M⁵), Karyopharm Therapeutics Inc. ($11.99M⁶), and Tvardi Therapeutics, Inc. ($13.33M⁷). Accendra Health, Inc. also passed the screen with a market cap of $15.73M, though it operates in Wholesale Trade⁸.
This screen identifies smaller companies that maintain analyst coverage. While coverage serves as a crude proxy for the level of scrutiny applied to a company's financials, passing this test does not establish that a stock is worth owning. The screen acts as a filter for historical data and does not provide a verdict on a company's value or future performance.
Educational tool. Not investment advice. This article was produced with automated assistance. Every figure in it was checked against the underlying data before it was published; the interpretation was not.